We are live on ! Find out more
GCGM

General Catalyst Group Management Portfolio holdings

AUM $184M
1-Year Est. Return 50.45%
This Fund
S&P 500
This Quarter Est. Return
-12.59%
1 Year Est. Return
+50.45%
3 Year Est. Return
+205.57%
5 Year Est. Return
+78.87%
10 Year Est. Return
AUM
$888M
AUM Growth
-$254M
Cap. Flow
-$125M
Cap. Flow %
-14.12%
Top 10 Hldgs %
99.97%
Holding
12
New
1
Increased
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
MAZE
Maze Therapeutics
MAZE
+$12.5M

Top Sells

Rank Stock Value
1
WRBY icon
Warby Parker
WRBY
+$137M
2
VRM icon
Vroom Inc
VRM
+$818K

Sector Composition

Rank Sector Weight
1 Technology 85.47%
2 Healthcare 7.51%
3 Industrials 3.8%
4 Consumer Discretionary 3.19%
5 Financials 0.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IOT icon
1
Samsara
IOT
$22.9B
$669M 75.33%
17,442,233
GTLB icon
2
GitLab
GTLB
$5.86B
$43.3M 4.88%
921,405
SNOW icon
3
Snowflake
SNOW
$99.4B
$38.7M 4.37%
265,081
EVLV icon
4
Evolv Technologies
EVLV
$995M
$33.7M 3.8%
10,796,148
CART icon
5
Maplebear
CART
$10.8B
$28.4M 3.19%
710,711
AVBP icon
6
ArriVent BioPharma
AVBP
$1.37B
$27.6M 3.11%
1,494,786
OSCR icon
7
Oscar Health
OSCR
$9.36B
$27.6M 3.11%
2,107,719
MAZE
8
Maze Therapeutics
MAZE
$1.5B
$11.4M 1.29%
+1,035,910
New +$12.5M
CMRC
9
Commerce.com Inc Series 1
CMRC
$263M
$6.91M 0.78%
1,200,000
PET
10
DELISTED
Wag!
PET
$1.05M 0.12%
6,976,530
VRM icon
11
Vroom Inc
VRM
$37.5M
$224K 0.03%
7,629
-30,516
-80% -$818K
WRBY icon
12
Warby Parker
WRBY
$3.13B
-5,656,571
Closed -$137M

Similar funds

General Catalyst Group Management's Q1 2025 Portfolio in Review

As of Q1 2025, General Catalyst Group Management held 12 positions worth $888M, down 22% from $1.14B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

General Catalyst Group Management withdrew a net $125M in Q1 2025, closing 1 position and reducing 1 holding. Its most notable exit was Warby Parker, an estimated $137M position sold in full.

By sector, the portfolio is most concentrated in Technology at 85% of assets, up from 76% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, General Catalyst Group Management opened a new position in Maze Therapeutics worth $11.4M.

  • General Catalyst Group Management's largest Q1 2025 buy was Maze Therapeutics: 1,035,910 shares worth $11.4M.
  • General Catalyst Group Management's biggest Q1 2025 reduction was Vroom Inc, cutting an estimated $818K.
  • General Catalyst Group Management fully exited Warby Parker in Q1 2025, selling an estimated $137M.
  • General Catalyst Group Management's ten largest holdings make up 100% of its $888M portfolio in Q1 2025.
  • General Catalyst Group Management opened 1 new position and closed 1 in Q1 2025.
  • General Catalyst Group Management's portfolio value fell 22% quarter-over-quarter to $888M.

Based on General Catalyst Group Management's 13F filing for Q1 2025, filed 16 Apr 2025.